Related Experiment Videos
Expression genomics and drug development: towards predictive pharmacology.
1Genome Institute of Singapore, 60 Biopolis Street, #02-01, 128672, Singapore. liue@gis.a-star.edu.sg
Briefings in Functional Genomics & Proteomics
|April 9, 2005
Summary
Expression genomics studies dynamic transcriptomes to find new biomarkers and drug targets. This approach accelerates drug development and identifies patient groups likely to benefit from new therapies.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Expression genomics investigates the dynamic transcriptome and its regulatory elements.
- Genome-wide transcript assessment technologies enable large-scale, time-series, and multi-sample analyses.
Purpose of the Study:
- To utilize comprehensive transcriptomic data for deciphering signaling pathways.
- To identify novel biomarkers and therapeutic targets.
- To predict prognostic potential and therapeutic outcomes.
Main Methods:
- Genome-wide transcriptomic profiling over time and across diverse samples.
- Analysis of dynamic transcriptome data.
- Multiplex approaches for complex interaction detection.
Main Results:
- Identification of potential biomarkers with prognostic value.
- Prediction of therapeutic outcomes based on transcriptomic data.
- Acceleration of drug discovery and development timelines.
Conclusions:
- Expression genomics provides a powerful framework for biomarker and target discovery.
- Multiplex transcriptomic analysis enhances the identification of drug combinations.
- This approach aids in stratifying patient populations for targeted therapies.